The World Health Organization (WHO) and Bayer AG, a pharmaceutical company based in Germany, have extended their partnership to aid countries affected by neglected tropical diseases (NTDs) through the provision of free treatments. Since 2002, Bayer AG has contributed medicines to WHO’s NTD efforts, now overseen by the Department of Malaria and Neglected Tropical Diseases (MNT). The agreement, renewed for another five years from 2025 to 2030, will continue supplying certified medicines and